Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2010 | 11-2009 | 11-2008 | 11-2007 | 12-2006 | |
| Sales | 1,601,883 | 867,891 | 1,049,716 | 931,633 | 0 |
| Cost of Goods | 1,322,115 | 742,615 | 891,139 | 762,582 | N/A |
| Gross Profit | 279,768 | 125,276 | 158,577 | 169,051 | N/A |
| Operating Expenses | 156,491 | 137,977 | 188,860 | 147,422 | 0 |
| Operating Income | 123,392 | -12,086 | -30,144 | 22,211 | N/A |
| Interest Expense | 41 | 23 | 114 | 303 | 0 |
| Other Income | 86 | 137 | 1,732 | 4,476 | 0 |
| Pre-tax Income | 123,437 | -11,972 | -28,526 | 26,384 | 0 |
| Income Tax | -15,991 | 4,442 | 19,383 | -1,725 | N/A |
| Net Income Continuous | 139,428 | -16,414 | -47,909 | 28,109 | N/A |
| Net Income | $139,428 | $-16,414 | $-47,909 | $28,109 | $N/A |
| EPS Basic Total Ops | 4.63 | -0.56 | -1.64 | 0.97 | N/A |
| EPS Basic Continuous Ops | 4.63 | -0.56 | -1.64 | 0.97 | N/A |
| EPS Diluted Total Ops | 4.46 | -0.56 | -1.64 | 0.94 | N/A |
| EPS Diluted Continuous Ops | 4.46 | -0.56 | -1.64 | 0.94 | N/A |
| EBITDA(a) | $145,497 | $10,050 | $24,764 | $43,198 | $N/A |